SHLN Stock Chart & Stats
$689.00
$0.00(0.00%)
At close: 4:00 PM EDT
$689.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$585.00 - $1,090.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$821.52B
Enterprise Value$50.98K
Total Cash (Recent Filing)$2.36B
Total Debt (Recent Filing)$15.00B
Price to Earnings (P/E)18.6
Beta-0.10
Next Earnings
Nov 05, 2026EPS Estimate
13.56Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.98
Shares Outstanding1,128,000,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio2.47
Price to Book (P/B)2.86
Price to Sales (P/S)2.20
P/FCF Ratio22.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$880.71Price Target Upside27.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)45
Revenue Forecast (FY)$472.42B
Bulls Say, Bears Say
Bulls Say
Strong Profitability MarginsSustained high gross and operating margins across the TTM period indicate durable product pricing power and cost structure advantages in imaging, diagnostics and therapy. These margins provide internal funding for R&D, service infrastructure and margin resilience through equipment cycle swings.
Solid Free Cash Flow GenerationConsistent positive FCF and a high FCF-to-net-income conversion rate support reinvestment, maintenance of service networks, dividend capacity and debt repayment. Over a 2–6 month horizon this cash profile underpins strategic optionality and stability despite occasional timing swings.
Recurring Annuity-like Revenue StreamsA large installed base plus consumables, service contracts and software subscriptions creates predictable, repeatable revenue and customer stickiness. This recurring mix smooths capital-equipment cyclicality and supports long-term margin sustainability and cross-sell opportunities.
Bears Say
Moderate, Persistent LeverageA debt-to-equity near 0.84 is manageable but not conservative; persistent leverage reduces financial flexibility for large investments or acquisitions and increases sensitivity to interest-rate moves. In adverse cycles this constrains capital allocation and heightens refinancing risk.
Revenue Growth VolatilityDependence on lumpy capital-equipment sales produces uneven top-line trends, making multi-period planning and margin expansion harder to sustain. This cyclicality can amplify operational swings in any 2–6 month window around ordering cycles and hospital budget timing.
Uneven Cash-flow Conversion Across YearsWhile recent FCF is strong, historical swings in free-cash-flow due to working-capital moves and investment timing reduce predictability. Intermittent weak conversion can pressure liquidity and delay deleveraging or strategic investments when equipment orders slow.
Siemens Healthineers AG News
SHLN FAQ
What was Siemens Healthineers AG’s price range in the past 12 months?
Siemens Healthineers AG lowest stock price was $585.00 and its highest was $1090.00 in the past 12 months.
What is Siemens Healthineers AG’s market cap?
Siemens Healthineers AG’s market cap is $821.52B.
When is Siemens Healthineers AG’s upcoming earnings report date?
Siemens Healthineers AG’s upcoming earnings report date is Nov 05, 2026 which is in 93 days.
How were Siemens Healthineers AG’s earnings last quarter?
Siemens Healthineers AG released its earnings results on Jul 31, 2026. The company reported $13.982 earnings per share for the quarter, beating the consensus estimate of $10.567 by $3.416.
Is Siemens Healthineers AG overvalued?
According to Wall Street analysts Siemens Healthineers AG’s price is currently Undervalued.
Does Siemens Healthineers AG pay dividends?
Siemens Healthineers AG does not currently pay dividends.
What is Siemens Healthineers AG’s EPS estimate?
Siemens Healthineers AG’s EPS estimate is 13.56.
How many shares outstanding does Siemens Healthineers AG have?
Siemens Healthineers AG has 1,128,000,000 shares outstanding.
What happened to Siemens Healthineers AG’s price movement after its last earnings report?
Siemens Healthineers AG reported an EPS of $13.982 in its last earnings report, beating expectations of $10.567. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Siemens Healthineers AG?
Currently, no hedge funds are holding shares in MX:SHLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Siemens Healthineers AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$880.71 (27.82% Upside)
$880.71 (27.82% Upside)
Blogger Sentiment
Bullish
MX:SHLN Sentiment 100%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.70%
12-Months-Change
Fundamentals
Return on Equity
3.29%
Trailing 12-Months
Asset Growth
-0.10%
Trailing 12-Months
Company Description
Siemens Healthineers AG
Siemens Healthineers AG, a subsidiary of Siemens Aktiengesellschaft with its headquarters in Erlangen, Germany, is a global leader in medical technology. The company develops, produces, and distributes a comprehensive portfolio of diagnostic and therapeutic products and services, catering to healthcare providers worldwide. Its operations are organized into four distinct business segments. The Imaging segment delivers advanced medical imaging systems, encompassing magnetic resonance imaging (MRI), computed tomography (CT), X-ray technology, molecular imaging, and ultrasound solutions. The Diagnostics segment focuses on providing in-vitro diagnostic products and services for laboratory, molecular, and point-of-care applications, alongside workflow optimization tools and informatics solutions for healthcare facilities. Varian, another key segment, specializes in cancer care, offering cutting-edge technologies, services, and integrated solutions to hospital oncology departments. This includes enhancing workflow efficiency, providing clinical services and consulting, and deploying digital platforms for treatment and therapy management. Lastly, the Advanced Therapies segment supplies sophisticated products designed to facilitate image-guided minimally invasive treatments across various medical fields, such as cardiology, interventional radiology, and surgery. Its offerings include angiography systems, mobile C-arms, and a robotic-assisted platform specifically for endovascular coronary and peripheral vascular procedures. Beyond these core offerings, Siemens Healthineers also provides a suite of essential support services, such as equipment performance management, clinical education and e-learning programs, asset management, managed departmental services for laboratories and healthcare facilities, and expert consulting and digital health services.
SHLN Company Deck
SHLN Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a predominantly positive operational story anchored by strong performance in Imaging and Precision Therapy—robust growth, margin expansion, product innovation and strategic milestones (Moody's rating, value partnerships). However, material near-term headwinds from Diagnostics in China, tariffs and foreign exchange created meaningful revenue and profit pressure and lowered short-term visibility (Q2 growth expected below guidance). Overall, strengths in the synergistic core were sufficient for management to confirm the full-year outlook, leaving the tone constructive but with clear risks to monitor in Diagnostics and macro/trade-related headwinds.View all MX:SHLN earnings summariesSHLN Stock 12 Month Forecast
Average Price Target
$880.71
▲(27.82% Upside)